La sarcoïdose est une affection inflammatoire granuiomateuse systémique d'origine inconnue touchant le plus fréquemment les poumons, le système lymphoïde, le foie, les yeux et la peau. Dans cet article, nous rapportons deux cas de sarcoïdose cutanée touchant les avant-bras de deux patients anciens toxicomanes traités par interféron-a et ribavirine pour une hépatite C chronique. Nous procédons à une revue de la littérature de la sarcoïdose induite par l'interféron et élaborons une nouvelle hypothèse pathogénique de l'effet Koebner dans la sarcoïdose cutanée. Dans le cas des deux patients que nous décrivons, la distribution des lésions cutanées coïncide avec les anciens sites d'injection d'héroïne le long des trajets veineux des deux avant- b...
Sarcoidosis is a systemic inflammatory disease, characterised by granuloma formation upon an unknown...
Introduction: Interferon lambdas (IFN-λs) are antiviral cytokines that restrict pathogen infection a...
Evolution of previous sarcoidosis under type 1 interferons given for severe associated diseas
La sarcoïdose est une affection inflammatoire granuiomateuse systémique d'origine inconnue touchant ...
Sarcoidosis is a systemic granulomatous disorder of unknown origin commonly affecting the lung, the ...
SummaryRecombinant interferon-α (rINF-α) is an immunomodulator used in the treatment of various cond...
Sarcoidosis is a multi-systemic inflammatory disease of unknown origin characterized by the presence...
A 61-year-old Japanese woman suffered from a small, painful, subcutaneous nodule on the sole of her ...
Interferon (IFN)-alpha with or without ribavirin is the treatment of choice for patients with chroni...
The treatment of chronic hepatitis C (CHC) has evolved in the past 15 years and combination of pegyl...
Interferon is used to treat hepatitis C virus infection and its cutaneous side effects are well know...
Introduction The principal secondary effects of anti-TNF alpha therapy are now well understood, part...
UNLABELLED: INTRODUCTION: With the increasing use of recombinant α and β interferon therapy for the...
Sarcoidosis is a systemic inflammatory disease, characterised by granuloma formation upon an unknown...
La sarcoïdose est une granulomatose multi-systémique d'étiologie inconnue. Une stimulation antigéniq...
Sarcoidosis is a systemic inflammatory disease, characterised by granuloma formation upon an unknown...
Introduction: Interferon lambdas (IFN-λs) are antiviral cytokines that restrict pathogen infection a...
Evolution of previous sarcoidosis under type 1 interferons given for severe associated diseas
La sarcoïdose est une affection inflammatoire granuiomateuse systémique d'origine inconnue touchant ...
Sarcoidosis is a systemic granulomatous disorder of unknown origin commonly affecting the lung, the ...
SummaryRecombinant interferon-α (rINF-α) is an immunomodulator used in the treatment of various cond...
Sarcoidosis is a multi-systemic inflammatory disease of unknown origin characterized by the presence...
A 61-year-old Japanese woman suffered from a small, painful, subcutaneous nodule on the sole of her ...
Interferon (IFN)-alpha with or without ribavirin is the treatment of choice for patients with chroni...
The treatment of chronic hepatitis C (CHC) has evolved in the past 15 years and combination of pegyl...
Interferon is used to treat hepatitis C virus infection and its cutaneous side effects are well know...
Introduction The principal secondary effects of anti-TNF alpha therapy are now well understood, part...
UNLABELLED: INTRODUCTION: With the increasing use of recombinant α and β interferon therapy for the...
Sarcoidosis is a systemic inflammatory disease, characterised by granuloma formation upon an unknown...
La sarcoïdose est une granulomatose multi-systémique d'étiologie inconnue. Une stimulation antigéniq...
Sarcoidosis is a systemic inflammatory disease, characterised by granuloma formation upon an unknown...
Introduction: Interferon lambdas (IFN-λs) are antiviral cytokines that restrict pathogen infection a...
Evolution of previous sarcoidosis under type 1 interferons given for severe associated diseas